Cite
McGuire A, Casey MC, Waldron RM, et al. Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers (Basel). 2020;12(7)doi: 10.3390/cancers12071820.
McGuire, A., Casey, M. C., Waldron, R. M., Heneghan, H., Kalinina, O., Holian, E., McDermott, A., Lowery, A. J., Newell, J., Dwyer, R. M., Miller, N., Keane, M., Brown, J. A. L., & Kerin, M. J. (2020). Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers, 12(7), . https://doi.org/10.3390/cancers12071820
McGuire, Andrew, et al. "Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer." Cancers vol. 12,7 (2020). doi: https://doi.org/10.3390/cancers12071820
McGuire A, Casey MC, Waldron RM, Heneghan H, Kalinina O, Holian E, McDermott A, Lowery AJ, Newell J, Dwyer RM, Miller N, Keane M, Brown JAL, Kerin MJ. Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers (Basel). 2020 Jul 07;12(7). doi: 10.3390/cancers12071820. PMID: 32645898; PMCID: PMC7408914.
Copy
Download .nbib